CardioNet, Inc. has set the terms for its IPO in an amended SEC filing. The systems provider for monitoring real-time patient information intends to sell some 6.6 million shares in a price range of $22 to $24 per share.
3.0 million shares will be from the company while 3.6 million of the shares will be from selling stockholders. The use of proceeds from the IPO will be to repay a term loan and to pay a fee to Silicon Valley Bank, part of SVB Financial (NASDAQ: SIVB); and the rest to make payments to former stockholders of PDSHeart Inc., a cardiac monitoring company CardioNet bought last March. The company has raised over $200 million in capital and initial efforts are focused on the diagnosis and monitoring of cardiac arrhythmias that is marketed as the CardioNet System. Since introduction of the CardioNet System in January 2003, physicians have enrolled over 109,000 patients.
Citigroup is the lead underwriter, with Lrhman, Leerink Swann, and Thomas Weisel also in the underwriting.
CardioNet will trade under the ticker "BEAT" on NASDAQ.
Jon C. Ogg
February 28, 2008
Is Your Money Earning the Best Possible Rate? (Sponsor)
Let’s face it: If your money is just sitting in a checking account, you’re losing value every single day. With most checking accounts offering little to no interest, the cash you worked so hard to save is gradually being eroded by inflation.
However, by moving that money into a high-yield savings account, you can put your cash to work, growing steadily with little to no effort on your part. In just a few clicks, you can set up a high-yield savings account and start earning interest immediately.
There are plenty of reputable banks and online platforms that offer competitive rates, and many of them come with zero fees and no minimum balance requirements. Click here to see if you’re earning the best possible rate on your money!
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.